Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 65 | 65 | 65 |
PDF Downloads | 53 | 53 | 53 |
During the 33rd Africa Cup of Nations (AFCON) football tournament in Cameroon, organizers and health authorities required a negative SARS-CoV-2 test result <48 hours before entry and provided free SARS-CoV-2 testing and vaccination at stadium and fan zone entrances. We describe the outcomes and implementation of mandatory SARS-CoV-2 testing at fan zones during AFCON. All consenting fan zones attendees were administered an electronic questionnaire capturing exposure factors, COVID-19-like symptoms, and COVID-19 vaccination status, before being tested for SARS-CoV-2 using an antigen rapid diagnostic test (Ag-RDT). Participants testing positive were sampled for confirmatory real-time SARS-CoV-2 polymerase chain reaction (PCR) and sequencing for variant surveillance. The case detection rate was estimated using PCR-confirmed cases, and the challenges were summarized from staff discussions and project/study documentation. In total, 4,820 fan zone attendees (median [interquartile range] age 30 [24–38], 27.7% females) were tested for SARS-CoV-2, including 1,228 (25.5%) fully vaccinated. Of 4,820 participants, 148 (3.1%) had a positive Ag-RDT result, of whom 67 consented to PCR testing and 19 of 64 (29.7%) were confirmed PCR-positive. The case detection rate was 40.1 (95% CI: 24.2–62.7) per 10,000 attendees. The Omicron variant (B.1.1.529) was found in all 11 samples successfully sequenced. The implementation of mandatory SARS-CoV-2 Ag-RDT at fan zone entrances was challenged by high attendance volume just prior to matches, lobbying of economic stakeholders, and inconsistent quality assurance when using test kits. Despite the challenges encountered, implementing mandatory SARS-CoV-2 Ag-RDT at fan zones, was a unique opportunity for SARS-CoV-2 case identification and genomic surveillance.
Financial support: This project was supported by FIND through a grant from the
Disclosure: The study protocol was approved by the Cameroon National Ethics Committee for Research in Human Health (No. 2021/12/1412) and the Advarra Institutional Review Board (Pro00060355) in the United States.
Current contact information: Boris K. Tchounga, Boris Tchakounte Youngui, André P. Goura, Loic Feuzeu, and Patrice Tchendjou, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon, and Washington, District of Columbia, E-mails: btchounga@pedaids.org, btchakounte@pedaids.org, agoura@pedaids.org, lfeuzeu@pedaids.org, and ptchendjou@pedaids.org. Emilienne Epée, National Public Health Emergency Operations Coordination Centre, Ministry of Public Health, Yaounde, Cameroon, and Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon, E-mail: epeeemilienne@gmail.com. Tatiana Djikeussi and Muhamed Awulo Mbunka, Elizabeth Glaser Pediatric AIDS Foundation Cameroon, Douala, Cameroon, E-mails: tdjikeussi@pedaids.org and ambunka@pedaids.org. Joseph Fokam, Virology Laboratory, Chantal BIYA International Reference Centre, Yaoundé, Cameroon, E-mail: josephfokam@gmail.com. Pallavi Dani, Foundation for Innovative New Diagnostics, Geneva, Switzerland, E-mail: pallavi.dani@finddx.org. Shannon Viana, Rhoderick Machekano, Laura Guay, Appolinaire Tiam, and Michelle M. Gill, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, E-mails: shannonviana@gmail.com, rmachekano@pedaids.org, lguay@pedaids.org, atiam@pedaids.org, and mgill@pedaids.org. Anne Hoppe, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland, E-mail: ahoppe@pedaids.org. Yap Boum, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon, E-mail: yap.boum2@pasteur-bangui.cf. Anne-Cecile Zoung-Kanyi Bissek, Division of Health Operational Research, Ministry of Public Health, Yaoundé, Cameroon, E-mail: annezkbissek@yahoo.fr. John Ditekemena, Elizabeth Glaser Pediatric AIDS Foundation, Kinshasa, Democratic Republic of the Congo, E-mail: jditekemena@pedaids.org. Alain G. Etoundi, Department of Disease, Epidemic and Pandemic Control, Ministry of Public Health, Yaoundé, Cameroon, E-mail: dretoundi@yahoo.fr.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 65 | 65 | 65 |
PDF Downloads | 53 | 53 | 53 |